about
Zika Virus: Medical Countermeasure Development ChallengesReanalysis of the anthrax epidemic in Rhodesia, 1978-1984Quality-of-life and surgical treatments for rectal cancer--a longitudinal analysis using the California Cancer Registry.Lifestyle and Risk of Hypertension: Follow-Up of a Young Pre-Hypertensive Cohort.Practices that reduce the Latina survival disparity after breast cancer.Construction and verification of CYP3A5 gene polymorphisms using a Saccharomyces cerevisiae expression system to predict drug metabolismA comparison of marginal odds ratio estimators.How Does Managed Care Improve the Quality of Breast Cancer Care Among Medicare-Insured Minority Women?Addressing refugee health through evidence-based policies: a case study.Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study.Xenotropic murine leukemia virus-related virus-associated chronic fatigue syndrome reveals a distinct inflammatory signature.The association of state law to breastfeeding practices in the US.Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010.Examination of health behaviours in a dynamic population.An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.Factors associated with time to availability for cases reported to population-based cancer registries.Cancer of unknown primary: time trends in incidence, United States.Application of the Transtheoretical Model to Cervical Cancer Screening in Latina Women.Arsenic Methylation Capacity and Metabolic Syndrome in the 2013-2014 U.S. National Health and Nutrition Examination Survey (NHANES).Breastfeeding laws and breastfeeding practices by race and ethnicity.The Association of State Law to Breastfeeding Practices in the US
P50
Q24261184-d04c6519-4702-bc91-08e8-e9664e7a291dQ28595683-53d6aed3-489e-3b35-a9b8-1a0a68d71959Q34026017-5b7e5714-4cbb-ff2b-8225-7c49f3e8b4edQ35942099-8bd3bf77-487a-5d4a-637e-7806d2b142f7Q37286964-91d94f85-4e67-a6da-61a8-0e7e51023f9cQ37720189-44cdcbed-4e93-2541-62dc-30ae783c5c51Q38227526-0982a9b9-4b97-5b02-df8e-263b8cb4e82dQ39688373-f14eed62-4770-c17c-48af-629d388342b8Q40181930-a9df074b-4bac-4522-2a0b-06c64a3f2c80Q40945373-4582c5e5-463f-4436-1fd0-04bbc2fa6981Q42202295-716a6a3b-468b-8b4e-33d9-e72c122b2547Q43708768-221c3aa3-4aca-2ff6-2251-ab70a3bc3526Q43881739-b042e176-4b55-e90b-3f47-ee8493c6d88cQ44457114-5ae9b0bc-4f55-31ed-da47-96ac53ae3083Q44958033-b959c422-47ae-6c4a-4ac6-8b478f87ec6dQ45072227-f64eb777-42d9-45da-1eae-9843a856b320Q45972483-ada9e875-4231-79dc-ba70-953dac7198efQ46416068-e573ee2b-4e94-bdb6-786f-a4737c087ebeQ47665856-333d15b9-4702-c52e-5f43-fe572d2e1da2Q47704149-9a4c91f9-40c4-e2c5-e559-ccc92a80f752Q47808945-54028b32-4644-4bbf-5f6b-342d7eb77a09Q59189016-ab0aba05-4e6e-030f-06d4-78f99d7a3571
P50
description
epidemiologist
@en
wetenschapper
@nl
name
Julie Smith-Gagen
@ast
Julie Smith-Gagen
@en
Julie Smith-Gagen
@es
Julie Smith-Gagen
@nl
type
label
Julie Smith-Gagen
@ast
Julie Smith-Gagen
@en
Julie Smith-Gagen
@es
Julie Smith-Gagen
@nl
altLabel
Julie A. Smith-Gagen
@en
Julie Smith Gagen
@en
Julie Smith
@en
prefLabel
Julie Smith-Gagen
@ast
Julie Smith-Gagen
@en
Julie Smith-Gagen
@es
Julie Smith-Gagen
@nl
P69
P106
P1153
8514183100
P1960
9CDNxPYAAAAJ
P2038
Julie_Smith-Gagen
P21
P31
P3829
P496
0000-0001-9796-3409